Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 6/20 | 0.52 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.52 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.52 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.45 |
| ▸ | CD69 | Q07108 | 1/20 | 0.43 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.41 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | GJA1 | P17302 | 1/20 | 0.39 |
| ▸ | GJB2 | P29033 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | IGF2R | P11717 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17465828 | 1.00 | LGALS3 (0.52) | LGALS3LGALS8LGALS4CHIACD69 | |
| SCHEMBL16999972 | 1.00 | LGALS3 (0.52) | LGALS3LGALS8LGALS4CHIACD69 | |
| SCHEMBL16641977 | 0.89 | LGALS3 (0.58) | LGALS3LGALS8LGALS4CHIACD69 | |
| SCHEMBL16999977 | 0.89 | LGALS3 (0.58) | LGALS3LGALS8LGALS4CHIACD69 | |
| SCHEMBL16996679 | 0.89 | LGALS3 (0.58) | LGALS3LGALS8LGALS4CHIACD69 | |
| SCHEMBL17718782 | 0.87 | LGALS3 (0.47) | LGALS3LGALS8LGALS4CHIACD69 | |
| SCHEMBL20175842 | 0.85 | LGALS3 (0.52) | LGALS3LGALS8LGALS4CHIACD69 | |
| SCHEMBL17849187 | 0.85 | LGALS3 (0.55) | LGALS3LGALS8LGALS4CHIACD69 | |
| SCHEMBL16996680 | 0.85 | LGALS3 (0.58) | LGALS3LGALS8LGALS4CHIACD69 | |
| SCHEMBL17849185 | 0.84 | LGALS3 (0.54) | LGALS3LGALS8LGALS4CHIACD69 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180142227-A1 | COAGULATION FACTOR VII POLYPEPTIDES | NOVO NORDISK HEALTHCARE AG (CH) | 2018-05-24 | — | — | US | disclosed |
| US-20170096655-A1 | COAGULATION FACTOR VII POLYPEPTIDES | NOVO NORDISK HEALTHCARE AG (CH) | 2017-04-06 | — | — | US | disclosed |
| US-20170035890-A1 | Coagulation Factor IX Conjugates | NOVO NORDISK HEALTHCARE AG (CH) | 2017-02-09 | — | — | US | disclosed |
| US-9371370-B2 | Coagulation factor VII polypeptides | NOVO NORDISK HEALTHCARE AG (CH) | 2016-06-21 | — | — | US | disclosed |
| US-20160120992-A1 | COAGULATION FACTOR VII POLYPEPTIDES | NOVO NORDISK HEALTHCARE AG (CH) | 2016-05-05 | — | — | US | disclosed |
| US-20150225710-A1 | Coagulation Factor IX Conjugates | NOVO NORDISK A/S | 2015-08-13 | — | — | US | disclosed |
| US-20150224203-A1 | Factor VIII Conjugates | NOVO NORDISK A/S (DK) | 2015-08-13 | — | — | US | disclosed |
| US-20150105321-A1 | COAGULATION FACTOR VII POLYPEPTIDES | NOVO NORDISK HEALTHCARE AG (CH) | 2015-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150105321-A1 | COAGULATION FACTOR VII POLYPEPTIDES | F7, F13B, HABP2 | LGALS3 2458/4885LGALS8 1604/4885LGALS4 2259/4885 |
| US-20170035890-A1 | Coagulation Factor IX Conjugates | F9, F13B, F13A1 | LGALS3 1443/4885LGALS8 2103/4885LGALS4 2684/4885 |
| US-20150225710-A1 | Coagulation Factor IX Conjugates | F9, F13B, F13A1 | LGALS3 1443/4885LGALS8 2103/4885LGALS4 2684/4885 |
| US-20180142227-A1 | COAGULATION FACTOR VII POLYPEPTIDES | F7, F13B, HABP2 | LGALS3 2458/4885LGALS8 1604/4885LGALS4 2259/4885 |
| US-20160120992-A1 | COAGULATION FACTOR VII POLYPEPTIDES | F7, F13B, HABP2 | LGALS3 2458/4885LGALS8 1604/4885LGALS4 2259/4885 |
| US-20170096655-A1 | COAGULATION FACTOR VII POLYPEPTIDES | F7, F13B, HABP2 | LGALS3 2458/4885LGALS8 1604/4885LGALS4 2259/4885 |
| US-20150224203-A1 | Factor VIII Conjugates | F8, F13B, F13A1 | LGALS3 2320/4885LGALS8 919/4885LGALS4 2059/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.